Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yunnan Jingxin Biotechnology
Kunming, Yunnan, Chinajingxin.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Yunnan Jingxin Biotechnology is a Chinese biotechnology company focused on the industrial hemp industry, specifically the cultivation, processing, and extraction of cannabinoids like cannabidiol (CBD). As a subsidiary of Zhejiang Jingxin Pharmaceutical, the company leverages pharmaceutical-grade standards to develop high-purity hemp-derived ingredients for medical and health applications. Its operations are centered in Yunnan Province, which is a primary hub for legal industrial hemp in China. The company aims to integrate hemp resources with pharmaceutical research to explore therapeutic uses in areas such as pain management and neurological health.
- Therapeutic areas
- ImmunologyNeurology
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Yunnan Jingxin Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yunnan Jingxin Biotechnology.